Correspondence: The use of IL-6 inhibitors in patients with COVID-19 who develop acute kidney injury
Turkish J Nephrol
.
2022 Oct;31(4):390.
doi: 10.5152/turkjnephrol.2022.22110410.
Epub 2022 Oct 12.
Authors
Yasar Caliskan
1
,
Krista L Lentine
1
Affiliation
1
SSM-Saint Louis University Hospital, St. Louis, MO, USA.
PMID:
36540691
PMCID:
PMC9762687
DOI:
10.5152/turkjnephrol.2022.22110410
No abstract available
Grants and funding
R01 DK120518/DK/NIDDK NIH HHS/United States